BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9042257)

  • 1. The alkylating antitumor drug tallimustine does not induce DNA repair.
    Rossi R; Montecucco A; Capolongo L; Mezzina M; Chevallier-Lagente O; Sarasin A; Ciarrocchi G
    Anticancer Res; 1996; 16(6B):3779-83. PubMed ID: 9042257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature influences both cytotoxicity and DNA nicking efficiency of the antitumor distamycin analogue FCE24517.
    Montecucco A; Capolongo L; Melegaro G; Mondello C; Ciarrocchi G
    Anticancer Res; 1994; 14(1A):189-92. PubMed ID: 8166448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologue.
    Baraldi PG; Romagnoli R; Spalluto G; Cozzi P; Mongelli N; Bianchi N; Gambari R
    Arzneimittelforschung; 2000 Mar; 50(3):309-15. PubMed ID: 10758785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin.
    Bigioni M; Salvatore C; Palma C; Manzini S; Animati F; Lombardi P; Pratesi G; Supino R; Zunino F
    Anticancer Drugs; 1997 Oct; 8(9):845-52. PubMed ID: 9402311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
    Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
    Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
    Marchini S; CirĂ² M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M
    Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-specific DNA alkylation of novel tallimustine derivatives.
    Marchini S; Cozzi P; Beria I; Geroni C; Capolongo L; D'Incalci M; Broggini M
    Anticancer Drug Des; 1998 Apr; 13(3):193-205. PubMed ID: 9595033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line.
    Erba E; Mascellani E; Pifferi A; D'Incalci M
    Int J Cancer; 1995 Jul; 62(2):170-5. PubMed ID: 7622292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective DNA interaction of the novel distamycin derivative FCE 24517.
    Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
    Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells.
    Baraldi PG; Balboni G; Romagnoli R; Spalluto G; Cozzi P; Geroni C; Mongelli N; Rutigliano C; Bianchi N; Gambari R
    Anticancer Drug Des; 1999 Feb; 14(1):71-6. PubMed ID: 10363029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific.
    Herzig MC; Trevino AV; Arnett B; Woynarowski JM
    Biochemistry; 1999 Oct; 38(42):14045-55. PubMed ID: 10529251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity.
    Baraldi PG; Romagnoli R; Giovanna Pavani M; del Carmen Nunez M; Bingham JP; Hartley JA
    Bioorg Med Chem; 2002 May; 10(5):1611-8. PubMed ID: 11886822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
    Coley HM; Mongelli N; D'Incalci M
    Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G; Imperatori L; Stefanini M; D'Incalci M
    Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue.
    Monks NR; Blakey DC; Curtin NJ; East SJ; Heuze A; Newell DR
    Br J Cancer; 2001 Sep; 85(5):764-71. PubMed ID: 11531265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
    Sunavala-Dossabhoy G; Van Dyke MW
    Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
    Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
    J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies.
    Baraldi PG; Beria I; Cozzi P; Geroni C; Espinosa A; Gallo MA; Entrena A; Bingham JP; Hartley JA; Romagnoli R
    Bioorg Med Chem; 2004 Jul; 12(14):3911-21. PubMed ID: 15210158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer.
    Weiss GR; Poggesi I; Rocchetti M; DeMaria D; Mooneyham T; Reilly D; Vitek LV; Whaley F; Patricia E; Von Hoff DD; O'Dwyer P
    Clin Cancer Res; 1998 Jan; 4(1):53-9. PubMed ID: 9516952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.